Filing Details

Accession Number:
0001179110-18-005850
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-04-24 21:06:22
Reporting Period:
2018-04-20
Accepted Time:
2018-04-24 21:06:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1034842 Rigel Pharmaceuticals Inc RIGL Pharmaceutical Preparations (2834) 943248524
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1419579 Anne-Marie Duliege Rigel Pharmaceuticals, Inc.
1180 Veterans Boulevard
South San Francisco CA 94080
Evp & Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-04-20 5,000 $4.11 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 26, 2018.
  2. The Reporting Person purchased these shares on December 29, 2017 under the Employee Stock Purchase Plan.